AMP-activated protein kinase (AMPK)
PO Box 616
6200 MD Maastricht
T: (+31) (0)43 3881979
Marie Miglianico graduated in 2011 from the French engineering school for life, food and environment sciences, AgroParisTech in Paris (France). During her studies, she received a very broad background in biology, ranging from agricultural sciences with an internship in Burkina Faso on biofuels, to genetics with a 6-month study on cystic fibrosis in Stanford University. After her engineering degree and her master in Life science and Technology, she joined the team of Dietbert Neumann, PhD in Maastricht University as a PhD candidate.
Her project aims at designing new small molecules able to prevent the AMP-activated protein kinase (AMPK) from binding to glycogen, in the context of insulin resistance and diabetes. This study will involve in silico drug design, molecular and cellular testing and in vivo assessment of drug candidates.